Evaluation of Drug-Drug Interactions of Modafinil and Armodafinil with Concurrent Antiretroviral Therapies: A Case Series

Abstract

Get full access to this article

View all access options for this article.

References

Nuvigil (Armodafinil) [prescribing information]. Teva Pharmaceuticals; 2017. Accessed April 19, 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021875s023lbl.pdf

Provigil (Modafinil) [prescribing information]. Cephalon Inc; 2007. Accessed April 19, 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020717s020s013s018lbl.pdf

Interaction checker. Liverpool HIV interactions. Accessed May 6, 2025. https://www.hiv-druginteractions.org/

Rowland

van Dyk

Warncken

Mangoni

Sorich

Rowland

Evaluation of modafinil as a perpetrator of metabolic drug-drug interactions using a model informed cocktail reaction phenotyping trial protocol. Br J Clin Pharmacol. 2018;84(3):501-509. doi:10.1111/bcp.13478

Darwish

Bond

Yang

Hellriegel

Robertson

Jr.

Evaluation of potential pharmacokinetic drug-drug interaction between armodafinil and aripiprazole in healthy adults. Pharmacopsychiatry. 2015;48(4-5):170-175. doi:10.1055/s-0035-1554671

Darwish

Bond

Hellriegel

Youakim

Yang

Robertson

Jr.

Investigation of a possible interaction between quetiapine and armodafinil in patients with schizophrenia: an open-label, multiple-dose study. J Clin Pharmacol. 2012;52(9):1399-1409. doi:10.1177/0091270011414572

Horn

Hansten

Chan

LN.

Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother. 2007;41(4):674-680. doi:10.1345/aph.1H423

Biktarvy (Bictegravir / Emtricitabine / Tenofovir Alafenamide) [prescribing information]. Gilead Pharmaceuticals; 2018. Accessed April 20, 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210251s000lbl.pdf

Tivicay (dolutegravir) [prescribing information]. ViiV Healthcare; 2013. Accessed April 20, 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204790lbl.pdf

10.

Cabenuva (Cabotegravir / Rilpivirine) [prescribing information]. ViiV Healthcare; 2021. Accessed May 5, 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212888s000lbl.pdf

11.

Orkin

Schapiro

Perno

, et al. Expanded multivariable models to assist patient selection for long-acting cabotegravir + rilpivirine treatment: clinical utility of a combination of patient, drug concentration, and viral factors associated with virologic failure. Clin Infect Dis. 2023;77(10):1423-1431. doi: 10.1093/cid/ciad370